Axonics is a medical technology company that develops and commercializes products for adults with bladder and bowel dysfunction, including: implantable sacral neuromodulation (SNM) systems to treat urinary urge incontinence and urinary urgency frequency, together referred to as overactive bladder, as well as fecal incontinence, and non-obstructive urinary retention; and a urethral bulking agent to treat female stress urinary incontinence. Co.'s proprietary rechargeable SNM system is designed to provide magnetic resonance imaging access, programmers, and long recharging interval among rechargeable SNM systems. We show 22 historical shares outstanding datapoints in our AXNX shares outstanding history coverage, used to compute AXNX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AXNX market cap history over the course of time is important for investors
interested in comparing AXNX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AXNX versus a peer is one thing; comparing
AXNX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AXNX can fluctuate over the course of history.
With this page we aim to empower investors researching AXNX by allowing them to research the AXNX market cap history. |
Free AXNX Email Alerts:
Video: The Importance of Market Cap
